Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,066 across all filing types
Latest filing 2009-02-13 Regulatory Filings
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
EXCHANGE NOTICE - RESUMPTION OF TRADING
Regulatory Filings Classification · 95% confidence The document is a short exchange notice regarding the resumption of trading for a specific stock code. It does not contain financial statements, management reports, or other substantive disclosures, but rather serves as a regulatory notification regarding market activity. As it does not fit into specific categories like M&A or share issues, it falls under the general regulatory filing category.
2009-02-13 English
PRICE SENSITIVE INFORMATION AND RESUMPTION OF TRADING
Capital/Financing Update Classification · 95% confidence The document is an announcement made pursuant to the Listing Rules of the Hong Kong Stock Exchange. It discusses the company's consideration of possible capital reorganisation and/or fund raising, notes a recent increase in trading volume and price, and mentions suspension and resumption of trading. The document is short (2947 characters) and primarily serves as a price sensitive information announcement and trading resumption notice. It does not contain financial statements, detailed financial data, or a full report. It is not a full capital/financing update report but rather an announcement about potential capital changes and trading status. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to capital reorganisation and fund raising proposals and trading resumption information.
2009-02-12 English
SUSPENSION OF TRADING
Regulatory Filings Classification · 95% confidence The document is a short announcement from Uni-Bio Science Group Limited regarding the suspension of trading of its shares pending the release of a price sensitive announcement. It is dated and signed by the Chairman and lists directors. The text explicitly states it is an announcement about trading suspension and does not contain any financial data, report content, or detailed analysis. The document length is only 1348 characters, which is very short and consistent with a brief regulatory announcement. There is no indication that this is a full report, earnings release, or management discussion. It fits the category of a Regulatory Filing (RNS) as a general regulatory announcement that does not fit other specific categories.
2009-02-12 English
EXCHANGE NOTICE - SUSPENSION OF TRADING
Delisting Announcement Classification · 95% confidence The document is a short exchange notice regarding the suspension of trading for a specific stock. It does not fit into specific categories like M&A, earnings, or financial reports. As it is a regulatory notice regarding market status that does not fit other specific categories, it is classified as a general regulatory filing.
2009-02-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2009
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31 January 2009, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related activities. The content focuses on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting monthly share capital movements, typical for compliance with exchange requirements. It is not an annual or interim report, earnings release, or management discussion. The document is comprehensive and contains substantive data on share capital changes, so it is not a brief announcement or report publication notice. The best fitting category is Regulatory Filings (RNS), as it is a general regulatory announcement about share capital movements that does not fit into more specific categories like Share Issue/Capital Change (SHA) because it reports monthly movements rather than a single event announcement.
2009-02-06 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31 January 2009, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related activities. The content focuses on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a Major Shareholding Notification or Share Issue/Capital Change. However, since it reports monthly movements in securities and share capital without announcing new share issues or capital changes per se, it aligns best with Major Shareholding Notification (MRQ) or Share Issue/Capital Change (SHA). Given the detailed monthly movements in issued shares and authorised capital, the document fits the Share Issue/Capital Change (SHA) category more precisely than MRQ, which is about significant share ownership threshold changes. The document is not an announcement of a report but the report itself, and it is substantive in length and detail.
2009-02-03 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.